ACC Rockies Chapter Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.


For more information and to register, please visit: ACC Rockies Chapter Meeting 2026



Alina Robert, MD, FACC Chapter President

Robert Duerr, MD, FACC Incoming Governor

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Twenty-Five Years Later: Remembering Sept. 11
    Today marks 25 years since Sept. 11, 2001 – a day forever etched into our collective memory. For those of us who lived through that morning, it can seem both a lifetime ago and only yesterday.
  • ACC, STS and SCAI Issue Joint Statement on TAVR National Coverage Determination
    The American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography & Interventions (SCAI) released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination finalized by the Centers for Medicare and Medicaid Services (CMS).
  • Look AHEAD: IL-6, Not hs-CRP, Identifies Risk of HF in Patients With T2D, Overweight/Obesity
    The inflammatory biomarker interleukin (IL)-6 identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity, particularly among those with no history of cardiovascular disease, according to results of a Look AHEAD ancillary study published Sept. 3 in JACC: Heart Failure.
  • GBD Study 2023: Myocarditis Burden Rising Despite Decline in DALYs, Mortality Rates
    Despite declines in disability-adjusted life years (DALYs) and mortality rates from myocarditis globally from 1990 to 2023, its incidence and prevalence remained stable, suggesting improvements in disease outcomes over time, according to a study using data from the GBD (Global Burden of Disease, Injuries, and Risk Factors Study) 2023 and published Sept. 2 in JACC.
  • Novel LA Staging Framework Stratifies NOAF Risk in HCM
    A novel left atrium (LA) staging framework proposed by Jaehyun Lim, MD, PhD, et al., was independently associated with a significant, stepwise increase in risk of new-onset atrial fibrillation (NOAF) in patients with hypertrophic cardiomyopathy (HCM), providing incremental predictive value beyond established atrial fibrillation (AFib) risk models, and may help tailor AFib surveillance strategies for […]